77 patents currently held
3 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Sep 2034. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Sep 2034
Next term end
62
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Oct 2037 · High confidence
Also notable
Ends Jul 2036 · High confidence
Also notable
Ends Sep 2034 · High confidence
Gene Sequencing Reaction Device, Gene Sequencing System, and Gene Sequencing Reaction Method
US 11,241,692
Cited by 5 later US patents, top 25% of utility patents granted in 2022 in our data. Protection runs to 2037.
DNA Sequencing Using Controlled Strand Displacement
US 10,227,647
Cited by 22 later US patents, top 25% of utility patents granted in 2019 in our data, and renewed at 2 of 3 maintenance windows. Protection runs to 2036.
Isolated oligonucleotide and use thereof in nucleic acid sequencing
US 9,890,375
The largest patent family in this portfolio, 7 related applications, renewed at every maintenance window due so far. Protection runs to 2034.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 3 fees due Dec 11 to 20, 2026 · next Dec 11
- 3 fees due Jan 4 to 16, 2027 · next Jan 4
- 2 fees due Feb 8 to 28, 2027 · next Feb 8
- 2 fees due Mar 19, 2027
- 1 fee due Apr 17, 2027The maintenance fee for Nucleic Acid Sequencing Using Affinity Reagents (US 11,788,138) comes due Apr 17, 2027. Unpaid by Oct 18, 2027, it lapses early.
- 3 fees due May 5 to 28, 2027 · next May 5
- 2 fees due Jun 3 to 5, 2027 · next Jun 3
- 2 fees due Jul 2 to 28, 2027 · next Jul 2
- 1 fee due Aug 18, 2027The maintenance fee for Primer for Nucleic Acid Random Fragmentation and Nucleic Acid Random Fragmentation Method (US 10,563,196) comes due Aug 18, 2027. Unpaid by Feb 18, 2028, it lapses early.
Recent changes
- 6 of the patents on this record were granted since Aug 16, 2026
What they patent
The 5 largest of its 62 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Isolated oligonucleotide and use thereof in nucleic acid sequencing | 4 in force | to Jul 2035 |
| Wafer Level Sequencing Flow Cell Fabrication | 3 in force | to Sep 2038 |
| Gene Sequencing Reaction Device, Gene Sequencing System, and Gene Sequencing Reaction Method | 3 in force | to Oct 2037 |
| DNA Sequencing Using Controlled Strand Displacement | 3 in force | to Jul 2036 |
| Systems and Methods for Optical Scanning and Imaging Through a Fluid Medium for Nucleic Acid Sequencing | 2 in force | to Jan 2042 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,890,375 | Isolated oligonucleotide and use thereof in nucleic acid sequencing In force · High confidence | In force | High confidence | |
| US 10,023,906 | Method for constructing nucleic acid single-stranded cyclic library and reagents thereof In force · High confidence | In force | High confidence | |
| US 10,954,559 | Bubble-shaped adaptor element and method of constructing sequencing library with bubble-shaped adaptor element In force · High confidence | In force | High confidence | |
| US 10,995,367 | Vesicular Adaptor and Uses Thereof in Nucleic Acid Library Construction and Sequencing In force · High confidence | In force | High confidence | |
| US 10,479,991 | Method and Reagent for Constructing Nucleic Acid Double-Linker Single-Strand Cyclical Library In force · High confidence | In force | High confidence | |
| US 10,351,848 | Method for Constructing Nucleic Acid Single-Stranded Cyclic Library and Reagents Thereof In force · High confidence | In force | High confidence | |
| US 10,344,317 | A Method and a Sequence Combination for Producing Nucleic Acid Fragments In force · High confidence | In force | High confidence | |
| US 10,316,356 | Method of Constructing Sequencing Library with Bubble-Shaped Adaptor Element In force · High confidence | In force | High confidence | |
| US 10,544,451 | Vesicular linker and uses thereof in nucleic acid library construction and sequencing In force · High confidence | In force | High confidence | |
| US 10,494,630 | Linker Element and Method of Using Same to Construct Sequencing Library In force · High confidence | In force | High confidence |
Also on record, not counted in the 77: 3 patents in force now held by others · 71 applications pending · 13 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.